Immunity and Safety of Covid-19 Synthetic Minigene Vaccine

NCT04276896 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Pathogen Infection Covid-19 Infection

Interventions

BIOLOGICAL: Injection and infusion of LV-SMENP-DC vaccine and antigen-specific CTLs

Sponsor

Shenzhen Geno-Immune Medical Institute

Collaborators

[object Object]
[object Object]